摘要:
The present invention provides novel 2-methylpropionic acid derivatives represented by the general formula: (wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group; R2 represents a hydrogen atom, a lower alkyl group or a halogen atom; A represents an oxygen atom or an imino group; the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration) and pharmaceutically acceptable salts thereof, which have excellent &bgr;3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of the biliary tract.
摘要翻译:本发明提供由以下通式表示的新型2-甲基丙酸衍生物:其中R 1表示氢原子,低级烷基或芳烷基; R 2表示氢原子,低级烷基或 卤素原子; A表示氧原子或亚氨基;由(R)表示的碳原子表示R构型的碳原子,标有(S)的碳原子表示S构型的碳原子)和药学上可接受的 其具有优异的β3肾上腺素能受体刺激作用,并且可用作预防或治疗肥胖症,高血糖症,由肠蠕动过多引起的疾病,尿频尿症,尿失禁,抑郁症或由胆汁结石或运动障碍引起的疾病 胆道。
摘要:
The present invention provides novel 2-methylpropionic acid derivatives represented by the general formula: (wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group; R2 represents a hydrogen atom a lower alkyl group or a halogen atom; A represents an oxygen atom or an imino group; the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration) and pharmaceutically acceptable salts thereof, which have excellent &bgr;3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of the biliary tract.
摘要翻译:本发明提供由以下通式表示的新型2-甲基丙酸衍生物:其中R 1表示氢原子,低级烷基或芳烷基; R 2表示氢原子,低级烷基或 卤素原子; A表示氧原子或亚氨基;由(R)标记的碳原子表示R构型的碳原子;标有(S)的碳原子表示S构型的碳原子)和药学上可接受的盐 其具有优异的β3肾上腺素能受体刺激作用,并且可用作预防或治疗肥胖症,高血糖症,由肠蠕动过多引起的疾病,尿尿症,尿失禁,抑郁症或由胆汁结石或运动障碍引起的疾病 胆道。
摘要:
The present invention provides novel phenoxyacetic acid derivatives represented by the general formula: wherein R1 represents a hydroxy group, a lower alkoxy group, an aralkoxy group, an amino group, or a mono or di(lower alkyl)amino group; one of R2 and R3 is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, while the other is a hydrogen atom; R4 represents a halogen atom, a lower alkyl group, a halo(lower alkyl) group, a hydroxy group, a lower alkoxy group, an aralkoxy group, a cyano group, a nitro group, an amino group, a mono or di(lower alkyl)amino group, a carbamoyl group, a mono or di(lower alkyl)carbamoyl group or a group represented by the general formula: —NHCOR5 (wherein R5 represents a hydrogen atom or a lower alkyl group); the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration, and pharmaceutically acceptable salts thereof, which have excellent &bgr;3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.
摘要:
The present invention provides novel phenylaminoalkyl-carboxylic acid derivatives represented by the general formula: (wherein R1 represents a hydroxy group, a lower alkoxy group, an aralkoxy group, an amino group, an alicyclic amino group or a mono or di(lower alkyl)amino group which may have a hydroxy group or a lower alkoxy group as a substituent; R2 represents a hydrogen atom or a lower alkyl group; R3 represents a hydrogen atom or a halogen atom; R4 and R5 are the same or different and each represents a hydrogen atom, a halogen atom or a lower alkyl group; A represents a lower alkylene group; the carbon atom marked with (R) represents a carbon atom in (R) configuration; and the carbon atom marked with (S) represents a carbon atom in (S) configuration) and pharmaceutically acceptable salts thereof, which have excellent &bgr;3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.
摘要:
Novel aminoethylphenoxyacetic acid derivatives represented by the general formula: (wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group; R2 represents a hydrogen atom or a halogen atom; the carbon atom marked with (R) represents a carbon atom in (R) configuration; and the carbon atom marked with (S) represents a carbon atom in (S) configuration) and pharmaceutically acceptable salts thereof, which have stimulating effects on both &bgr;2- and &bgr;3-adrenoceptors and are useful as agents for relieving pain and promoting the removal of calculi in urolithiasis.
摘要:
A brain information output apparatus includes an intention determination information storage unit in which two or more pieces of intention determination information can be stored, with each intention determination information including a pair of an intention identifier, and a learning feature amount group including one or more feature amounts extracted from second learning data that is obtained by converting first learning data into intracerebral brain activity data, the first leaning data being acquired from the outside of the cranium of a user when the user performs a trial according to one intention; a first brain activity data acquiring unit that acquires first brain activity data from the outside of the cranium of a user; a second brain activity data acquiring unit that converts the first brain activity data to intracerebral brain activity data, and acquires second brain activity data; a feature amount group acquiring unit that acquires, from the second brain activity data, an input feature amount group including one or more feature amounts; an intention identifier acquiring unit that acquires an intention identifier corresponding to the input feature amount group based on the two or more pieces of intention determination information; and an intention identifier output unit that outputs the intention identifier.
摘要:
A support arm that is rockably supported on one end of a grip portion and projects from the one end is provided. Both ends of a blade head are supported by the support arm such that the blade head can rock around an axis extending along a reciprocating direction of an inner blade, and an axial direction of the rocking motion of the support arm with respect to the grip portion is set in a direction intersecting with the reciprocating direction of the inner blade. This configuration achieves an electric shaver capable of increasing the movable range of the blade head while preventing a main body from increasing in size.
摘要:
The self-standing bag comprises a package for accommodating a content, a port provided in the center of the top portion of the package, and reinforcing members formed of a thermoplastic resin which cover the outer faces of both side edges of the package. The lower end portion of the reinforcing member is located above the bottom edge of the package. The lower end portion of the reinforcing member is projected inward of a lower cutout.
摘要:
The present invention aims to provide hepatitis C virus inhibitors capable of inhibiting viral replication in hepatitis C virus-infected cells.The replication of hepatitis C virus can be inhibited and hepatitis C virus-infected cells can be specifically injured by specifically inhibiting BGT-1 or AKR1C1 involved in the replication of hepatitis C virus. Thus, viral inhibitors comprising a substance inhibiting BGT-1 or AKR1C1 are effective for the treatment of hepatitis C.
摘要:
An electric shaver in which a blade frame part is attached to an upper portion of a body part, the blade frame part including an outer blade, an outer blade frame to fix the outer blade thereto, a holding frame to hold the outer blade frame vertically movable, and an outer peripheral frame connected to the holding frame, the upper portion including an inner blade. The holding frame is detachably attached to the outer peripheral frame from an under side thereof, and the outer peripheral frame entirely covers an outer periphery of the holding frame.